MedTrace Logo

Efficacy of Telerehabilitation in the Patients With Aphasia

NCT02694133 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2016-02-29

No results posted yet for this study

Summary

The study will invite 30 patients to join, and they will be arranged in the face to face group and telerehabilitation group randomly.

In the telerehabilitation group, the investigators use the mobile device, which with the camera and speaker, for patients to practice the naming training at home, and assess the speech ability every 2-4weeks by speech therapist via telerehabilitation platform.

Concise Chinese Aphasia Test (CCAT) and ASHA FACS conceptual framework Test will be used as the assessment tool for evaluation speech ability and functional ability.

The investigators expect that patients can improve their speech ability, functional ability, and quality of life via telerehabilitation speech therapy.

And the investigators can establish the standard telerehabilitation speech therapy protocol for aphasia therapy.

Conditions

  • Aphasia

Interventions

PROCEDURE

Smart Phone Based Assistive Speech Therapeutic System

use the mobile device, which with the camera and speaker, for patients to practice the naming training at home, and assess the speech ability every 2-4weeks by speech therapist via telerehabilitation platform. Concise Chinese Aphasia Test (CCAT) will be used as the assessment tool for evaluation speech ability and functional ability.

PROCEDURE

Mobile phone-based tele rehabilitation program

Mobile phone-based tele rehabilitation program

Sponsors & Collaborators

  • Kaohsiung Veterans General Hospital.

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-12-31
Completion
2012-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02694133 on ClinicalTrials.gov